PCR-based detection of A. fumigatus Cyp51A mutations on bronchoalveolar lavage. A multi-center validation of the AsperGenius assay® in 201 patients with hematological disease suspected for invasive aspergillosis

[1]  P. White,et al.  Analytical and Clinical Evaluation of the PathoNostics AsperGenius Assay for Detection of Invasive Aspergillosis and Resistance to Azole Antifungal Drugs Directly from Plasma Samples , 2017, Journal of Clinical Microbiology.

[2]  J. Meis,et al.  Interspecies discrimination of A. fumigatus and siblings A. lentulus and A. felis of the Aspergillus section Fumigati using the AsperGenius® assay. , 2017, Diagnostic microbiology and infectious disease.

[3]  J. Cornelissen,et al.  PCR-based detection of Aspergillus fumigatus Cyp51A mutations on bronchoalveolar lavage: a multicentre validation of the AsperGenius assay® in 201 patients with haematological disease suspected for invasive aspergillosis. , 2016, The Journal of antimicrobial chemotherapy.

[4]  D. Denning,et al.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  C. Tzeng,et al.  Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantation. , 2016, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[6]  J. Frisvad,et al.  Extrolites of Aspergillus fumigatus and Other Pathogenic Species in Aspergillus Section Fumigati , 2016, Front. Microbiol..

[7]  H. Greinix,et al.  Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study , 2015, BMC Infectious Diseases.

[8]  G. Driessen,et al.  Diagnostic Performance of Galactomannan Antigen Testing in Cerebrospinal Fluid , 2015, Journal of Clinical Microbiology.

[9]  W. Melchers,et al.  Azole Resistance in Aspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles? , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  J. Meis,et al.  High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients. , 2015, The Journal of antimicrobial chemotherapy.

[11]  B. Ener,et al.  First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey. , 2015, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[12]  S. Polinder,et al.  Aerosolised liposomal amphotericin B to prevent aspergillosis in acute myeloid leukaemia: Efficacy and cost effectiveness in real-life. , 2015, International journal of antimicrobial agents.

[13]  S. Seyedmousavi,et al.  International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus. , 2015, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[14]  P. Hauser,et al.  Prospective Multicenter International Surveillance of Azole Resistance in Aspergillus fumigatus , 2015, Emerging infectious diseases.

[15]  T. Walsh,et al.  Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: a single‐centre study with focus on emerging pathogens , 2015, Mycoses.

[16]  He Huang,et al.  Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[17]  J. Buer,et al.  Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany. , 2015, The Journal of antimicrobial chemotherapy.

[18]  P. White,et al.  Analytical and Clinical Evaluation of the PathoNostics AsperGenius Assay for Detection of Invasive Aspergillosis and Resistance to Azole Antifungal Drugs during Testing of Serum Samples , 2015, Journal of Clinical Microbiology.

[19]  G. Simons,et al.  Validation of a New Aspergillus Real-Time PCR Assay for Direct Detection of Aspergillus and Azole Resistance of Aspergillus fumigatus on Bronchoalveolar Lavage Fluid , 2015, Journal of Clinical Microbiology.

[20]  R. Samson,et al.  Genetic Relatedness versus Biological Compatibility between Aspergillus fumigatus and Related Species , 2014, Journal of Clinical Microbiology.

[21]  W. Hofmann,et al.  Incidence of Cyp51 A Key Mutations in Aspergillus fumigatus—A Study on Primary Clinical Samples of Immunocompromised Patients in the Period of 1995–2013 , 2014, PloS one.

[22]  A. Chowdhary,et al.  Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms. , 2014, Future microbiology.

[23]  P. Chiusolo,et al.  Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO). , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[24]  E. Rietschel,et al.  Prevalence and molecular characterization of azole resistance in Aspergillus spp. isolates from German cystic fibrosis patients. , 2014, The Journal of antimicrobial chemotherapy.

[25]  J. Blanco,et al.  Polyphasic characterization of fungal isolates from a published case of invasive aspergillosis reveals misidentification of Aspergillus felis as Aspergillus viridinutans. , 2014, Journal of medical microbiology.

[26]  K. Lagrou,et al.  Azole resistance in Aspergillus fumigatus: a growing public health concern. , 2013, Current opinion in infectious diseases.

[27]  B. Ener,et al.  A Case Report on Aspergillus lentulus Pneumonia. , 2013, Balkan medical journal.

[28]  L. Pagano,et al.  SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients , 2013, Infection.

[29]  F. V. van Tiel,et al.  Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  K. Ballen,et al.  Risk factors for invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a single center experience. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[31]  M. Nucci,et al.  Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in Brazil. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[32]  M. Arendrup,et al.  Azole resistance in Aspergillus fumigatus from bronchoalveolar lavage fluid samples of patients with chronic diseases. , 2013, The Journal of antimicrobial chemotherapy.

[33]  J. Houbraken,et al.  Aspergillus felis sp. nov., an Emerging Agent of Invasive Aspergillosis in Humans, Cats, and Dogs , 2013, PloS one.

[34]  C. Thompson,et al.  Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10‐year, single‐center experience , 2013, Transplant infectious disease : an official journal of the Transplantation Society.

[35]  M. Christner,et al.  cyp51A-Based Mechanisms of Aspergillus fumigatus Azole Drug Resistance Present in Clinical Samples from Germany , 2013, Antimicrobial Agents and Chemotherapy.

[36]  P. Escribano,et al.  Is Azole Resistance in Aspergillus fumigatus a Problem in Spain? , 2013, Antimicrobial Agents and Chemotherapy.

[37]  J. Blanco,et al.  Invasive aspergillosis caused by cryptic Aspergillus species: a report of two consecutive episodes in a patient with leukaemia. , 2013, Journal of medical microbiology.

[38]  S. Antinori,et al.  Aspergillus meningitis: A rare clinical manifestation of central nervous system aspergillosis. Case report and review of 92 cases , 2012, Journal of Infection.

[39]  E. Mylonakis,et al.  Central Nervous System Aspergillosis: A Series of 14 Cases From a General Hospital and Review of 123 Cases From the Literature , 2012, Medicine.

[40]  Xinhua Liu,et al.  Classification accuracy and cut point selection , 2012, Statistics in medicine.

[41]  F. Ruschitzka,et al.  Fatal outcome after heart transplantation caused by Aspergillus lentulus , 2012, Transplant infectious disease : an official journal of the Transplantation Society.

[42]  D. Horn,et al.  The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012. , 2012, Diagnostic microbiology and infectious disease.

[43]  W. Hofmann,et al.  Development of Novel PCR Assays To Detect Azole Resistance-Mediating Mutations of the Aspergillus fumigatus cyp51A Gene in Primary Clinical Samples from Neutropenic Patients , 2012, Antimicrobial Agents and Chemotherapy.

[44]  M. Antonelli,et al.  Diagnosis of Invasive Aspergillosis by a Commercial Real-Time PCR Assay for Aspergillus DNA in Bronchoalveolar Lavage Fluid Samples from High-Risk Patients Compared to a Galactomannan Enzyme Immunoassay , 2011, Journal of Clinical Microbiology.

[45]  F. V. van Tiel,et al.  Clinical Implications of Azole Resistance in Aspergillus fumigatus, the Netherlands, 2007–2009 , 2011, Emerging infectious diseases.

[46]  A. Sarmento,et al.  Aspergillus viridinutans: an agent of adult chronic invasive aspergillosis. , 2011, Medical mycology.

[47]  E. Mellado,et al.  Role of Aspergillus lentulus 14-α Sterol Demethylase (Cyp51A) in Azole Drug Susceptibility , 2011, Antimicrobial Agents and Chemotherapy.

[48]  S. Lockhart,et al.  Azole Resistance in Aspergillus fumigatus Isolates from the ARTEMIS Global Surveillance Study Is Primarily Due to the TR/L98H Mutation in the cyp51A Gene , 2011, Antimicrobial Agents and Chemotherapy.

[49]  A. Thiébaut,et al.  European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update , 2011, Bone Marrow Transplantation.

[50]  B. Barlogie,et al.  Probable invasive aspergillosis without prespecified radiologic findings: proposal for inclusion of a new category of aspergillosis and implications for studying novel therapies. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[51]  L. Qiu,et al.  Risk factors and prognosis of invasive fungal infections in allogeneic stem cell transplantation recipients: a single‐institution experience , 2010, Transplant infectious disease : an official journal of the Transplantation Society.

[52]  Thomas J Walsh,et al.  Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[53]  W. Melchers,et al.  Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use? , 2009, The Lancet. Infectious diseases.

[54]  A. Ibatici,et al.  Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients , 2009, Bone Marrow Transplantation.

[55]  D. Denning,et al.  Frequency and Evolution of Azole Resistance in Aspergillus fumigatus Associated with Treatment Failure , 2009, Emerging infectious diseases.

[56]  W. Melchers,et al.  Possible Environmental Origin of Resistance of Aspergillus fumigatus to Medical Triazoles , 2009, Applied and Environmental Microbiology.

[57]  M. Mujica,et al.  Phenotypic and genotypic characterization of Aspergillus lentulus and Aspergillus fumigatus isolates in a patient with probable invasive aspergillosis. , 2009, Journal of medical microbiology.

[58]  I. Yakoub-Agha,et al.  Diagnosis of invasive aspergillosis using bronchoalveolar lavage in haematology patients: influence of bronchoalveolar lavage human DNA content on real-time PCR performance , 2009, European Journal of Clinical Microbiology & Infectious Diseases.

[59]  E. Anaissie,et al.  Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[60]  E. Steyerberg,et al.  Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: an observational study. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[61]  K. Marr,et al.  Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[62]  Patricia Muñoz,et al.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[63]  W. Hop,et al.  Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[64]  Raoul Herbrecht,et al.  Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[65]  L. Pagano,et al.  Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[66]  J. Lipton,et al.  Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. , 2007, The New England journal of medicine.

[67]  D. Nickle,et al.  Aspergillus lentulus sp. nov., a New Sibling Species of A. fumigatus , 2005, Eukaryotic Cell.

[68]  A. Paetau,et al.  Central nervous system aspergillosis in allogeneic stem cell transplant recipients , 2003, Bone Marrow Transplantation.

[69]  A. Warris,et al.  Multidrug resistance in Aspergillus fumigatus. , 2002, The New England journal of medicine.

[70]  Richard Sylvester,et al.  Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. , 2002, The New England journal of medicine.

[71]  C. Viscoli,et al.  Aspergillus Galactomannan Antigen in the Cerebrospinal Fluid of Bone Marrow Transplant Recipients with Probable Cerebral Aspergillosis , 2002, Journal of Clinical Microbiology.

[72]  E. Mellado,et al.  Identification of Two Different 14-α Sterol Demethylase-Related Genes (cyp51A and cyp51B) in Aspergillus fumigatus and Other Aspergillus species , 2001, Journal of Clinical Microbiology.

[73]  J. Rowe,et al.  Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: Before and after chemoprophylaxis and institution of HEPA filters , 2001, American journal of hematology.

[74]  S J Lin,et al.  Aspergillosis case-fatality rate: systematic review of the literature. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[75]  Y. Tanaka,et al.  Early diagnosis of central nervous system aspergillosis using polymerase chain reaction, latex agglutination test, and enzyme‐linked immunosorbent assay , 1999, British journal of haematology.

[76]  W. Siegert,et al.  Aerosolized amphotericin B inhalations as prophylaxis of invasive aspergillus infections during prolonged neutropenia: results of a prospective randomized multicenter trial. , 1999, Blood.

[77]  M. Griese,et al.  Amphotericin B and pulmonary surfactant. , 1998, European journal of medical research.

[78]  D. Denning.  Therapeutic outcome in invasive aspergillosis. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[79]  S. Natsch,et al.  Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in The Netherlands in 2015 : NethMap 2016 , 2016 .

[80]  W. Melchers,et al.  Azole, polyene and echinocandin MIC distributions for wild-type, TR34/L98H and TR46/Y121F/T289A Aspergillus fumigatus isolates in the Netherlands. , 2015, The Journal of antimicrobial chemotherapy.

[81]  M. Girardis,et al.  Detection of Pneumocystis jirovecii and Aspergillus spp. DNa in bronchoalveolar lavage fluids by commercial real-time PCr assays: comparison with conventional diagnostic tests. , 2015, The new microbiologica.

[82]  Donna Haiduven,et al.  Nosocomial aspergillosis and building construction. , 2009, Medical mycology.

[83]  A. Wilmer,et al.  Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. , 2008, American journal of respiratory and critical care medicine.

[84]  A. del Palacio,et al.  Isolation of Aspergillus lentulus in Spain from a critically ill patient with chronic obstructive pulmonary disease. , 2008, Revista iberoamericana de micologia.

[85]  L. Pagano,et al.  Design and Methods , 2022 .

[86]  R. Barbó,et al.  Combination Antifungal Therapy for Invasive Aspergillosis , 2005 .